BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12124492)

  • 1. [Immunochemistry and genotype analysis of tumors. Second part: What future for the molecular diagnosis of tumors?].
    Soussi T
    Ann Pathol; 2002 Apr; 22(2):113-20. PubMed ID: 12124492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemistry and genotype analysis of tumors. First part: Which future for the immunochemical diagnosis of cancer?].
    Svrcek M; Sabourin JC
    Ann Pathol; 2002 Apr; 22(2):102-12. PubMed ID: 12124491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetics and cancer: fundamental and clinical aspects].
    Soussi T
    Cancer Radiother; 2001 Nov; 5 Suppl 1():36s-41s. PubMed ID: 11797283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genotypic analysis and immunohistochemistry in human cancers: conflicting or complementary information?].
    Puisieux A
    Ann Pathol; 2002 Apr; 22(2):93-5. PubMed ID: 12124489
    [No Abstract]   [Full Text] [Related]  

  • 5. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
    Adsay NV; Basturk O; Cheng JD; Andea AA
    Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.
    Haven CJ; Howell VM; Eilers PH; Dunne R; Takahashi M; van Puijenbroek M; Furge K; Kievit J; Tan MH; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Dralle H; Hoang-Vu C; Gimm O; Morreau H; Marsh DJ; Teh BT
    Cancer Res; 2004 Oct; 64(20):7405-11. PubMed ID: 15492263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumors.
    Agaram NP; Besmer P; Wong GC; Guo T; Socci ND; Maki RG; DeSantis D; Brennan MF; Singer S; DeMatteo RP; Antonescu CR
    Clin Cancer Res; 2007 Jan; 13(1):170-81. PubMed ID: 17200352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New technologies to assess genotype-phenotype relationships.
    Bochner BR
    Nat Rev Genet; 2003 Apr; 4(4):309-14. PubMed ID: 12671661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
    Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic and phenotypic classification of cancer: How should the impact of the two diagnostic approaches best be balanced?
    Brandal P; Teixeira MR; Heim S
    Genes Chromosomes Cancer; 2010 Sep; 49(9):763-74. PubMed ID: 20607708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular medicine tools. Future prospects with new techniques].
    Landegren U; Kamali-Moghaddam M; Nilsson M
    Lakartidningen; 2006 Oct 4-10; 103(40):2947-52. PubMed ID: 17115654
    [No Abstract]   [Full Text] [Related]  

  • 14. Genotype-phenotype relationships in hepatocellular tumors from mice and man.
    Stahl S; Ittrich C; Marx-Stoelting P; Köhle C; Altug-Teber O; Riess O; Bonin M; Jobst J; Kaiser S; Buchmann A; Schwarz M
    Hepatology; 2005 Aug; 42(2):353-61. PubMed ID: 15965925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine needle biopsy and genetics, two allied weapons in the diagnosis, prognosis, and target therapeutics of solid pediatric tumors.
    Barroca H
    Diagn Cytopathol; 2008 Sep; 36(9):678-84. PubMed ID: 18677757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling of human cancer: new opportunities.
    Englert CR; Petricoin EF; Krizman DB; Emmert-Buck MR
    Curr Opin Mol Ther; 1999 Dec; 1(6):712-9. PubMed ID: 19629868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
    Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
    Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General morphological and biological features of neoplasms: integration of molecular findings.
    Diaz-Cano SJ
    Histopathology; 2008 Jul; 53(1):1-19. PubMed ID: 18282144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
    Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
    Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.